대리모 출산 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Surrogacy Market was valued at USD 22.4 billion in 2024 and is expected to expand at a CAGR of 24.6% from 2025 to 2034. This industry encompasses a range of technologies and services that assist individuals and couples in having children through surrogacy. Key players include fertility clinics, hospitals, and medical professionals specializing in assisted reproductive technology (ART). The demand for surrogacy continues to grow, driven by rising awareness, technological advancements in ART, and increased accessibility to fertility treatments. Additionally, changing societal norms and legal frameworks supporting surrogacy contribute to market expansion. With the growing prevalence of infertility and delayed parenthood, the need for reliable reproductive solutions is at an all-time high.

The market is segmented into gestational and traditional surrogacy, with gestational surrogacy leading at USD 21.4 billion in 2024. This segment is set to grow at a CAGR of 24.9% due to regulatory approvals and structured frameworks in various countries. The legal recognition of gestational surrogacy over traditional methods makes it a more viable choice for intended parents.

By technology, the market is categorized into intrauterine insemination (IUI) and in-vitro fertilization (IVF), with IVF further divided into classical IVF and intracytoplasmic sperm injection (ICSI). The IVF segment held a 63.4% market share in 2024 and is projected to grow at a 24.7% CAGR. The rising infertility rate, coupled with evolving reproductive options, fuels demand for IVF-based surrogacy.

The market is also segmented by age group, with categories including below 35 years, 35-37 years, 38-39 years, 40-42 years, 43-44 years, and over 44 years. The below-35 segment is expanding rapidly, with a projected 25.1% CAGR. This growth is attributed to higher success rates in IVF procedures for younger women, making them the preferred choice for surrogacy programs.

By end use, the market is divided into hospitals, fertility clinics, and others, with fertility clinics dominating at 63.3% market share in 2024. These clinics serve as comprehensive centers for surrogacy, offering medical, legal, and psychological support, along with advanced fertility treatments. Their role in streamlining the surrogacy process further strengthens their position in the market.

Regionally, the U.S. led the North American surrogacy market in 2024, generating USD 5.1 billion in revenue. The increasing infertility rate among individuals and couples drives market demand. Rising acceptance of ART, coupled with strong regulatory support, is expected to fuel continued growth in the surrogacy industry.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing number of infertility cases
    • 3.2.1.2 Rising awareness about the infertility treatment options available in the market
    • 3.2.1.3 Increasing adoption of sedentary lifestyle and unhealthy eating habits leading to hormonal change
    • 3.2.1.4 Increasing number of fertility clinics
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Stringent regulations pertaining commercial surrogacy
    • 3.2.2.2 High cost involved in surrogacy procedure
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Gestational surrogacy
• 5.3 Traditional surrogacy

Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Intrauterine insemination (IUI)
• 6.3 In-vitro fertilization (IVF)
  • 6.3.1 Classical/standard IVF
  • 6.3.2 Intracytoplasmic sperm injection (ICSI)
• 6.4 Other technologies

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Below 35 years
• 7.3 35-37 years
• 7.4 38 - 39 years
• 7.5 40-42 years
• 7.6 43-44 years
• 7.7 Over 44 years

Chapter 8 Market Estimates and Forecast, By Service Provider, 2021 – 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Fertility clinics
• 8.4 Other service providers

Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Czech Republic
  • 9.3.2 Estonia
  • 9.3.3 Georgia
  • 9.3.4 Greece
  • 9.3.5 Poland
  • 9.3.6 Sweden
  • 9.3.7 UK
• 9.4 Asia Pacific
  • 9.4.1 India
  • 9.4.2 Thailand
  • 9.4.3 South Korea
  • 9.4.4 Australia
• 9.5 Africa
  • 9.5.1 Kenya
  • 9.5.2 Nigeria
  • 9.5.3 South Africa

Chapter 10 Company Profiles

• 10.1 IVIRMA
• 10.2 Bangkok IVF Center
• 10.3 Boston IVF
• 10.4 Bourn Hall International (TVM Capital Healthcare)
• 10.5 Circle Surrogacy
• 10.6 Extraordinary Conceptions
• 10.7 Growing Generations
• 10.8 Houston Fertility Center
• 10.9 Kindbody
• 10.10 Max Healthcare
• 10.11 MLSPL (Morpheus IVF Clinic)
• 10.12 New Hope Fertility Clinic
• 10.13 NOVA IVF
• 10.14 Ovation Fertility
• 10.15 Scanfert Clinic